We further validated the NFAT3 interaction with RERG by PLA assays (Figure 4A) in luminal breast cancer tissues (Figure 4C) obtained from patients with (10 patients) or without (11 patients) distant ALN metastases at diagnosis. Here, NFATC4 is linked to breast carcinoma.